ABEO Logo

Abeona Therapeutics Inc. (ABEO) 

NASDAQ
Market Cap
$257.78M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
228 of 966
Rank in Industry
141 of 554

Largest Insider Buys in Sector

ABEO Stock Price History Chart

ABEO Stock Performance

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

Insider Activity of Abeona Therapeutics Inc.

Over the last 12 months, insiders at Abeona Therapeutics Inc. have bought $241,836 and sold $269,416 worth of Abeona Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Abeona Therapeutics Inc. have bought $226,097 and sold $1.07M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Seshadri Vishwas (Chief Executive Officer) — $119,800. Alland Leila (director) — $103,598. Vazzano Joseph Walter (Chief Financial Officer) — $35,218.

The last purchase of 11,000 shares for transaction amount of $51,799 was made by Alland Leila (director) on 2024‑05‑16.

List of Insider Buy and Sell Transactions, Abeona Therapeutics Inc.

2024-06-18Saledirector
25,821
0.0635%
$4.51$116,453+27.09%
2024-06-18Saledirector
25,890
0.0637%
$4.51$116,764+27.09%
2024-05-16Purchasedirector
11,000
0.0286%
$4.71$51,799+20.24%
2024-04-26Purchasedirector
7,550
0.0265%
$3.28$24,764+65.03%
2024-04-25PurchaseChief Executive Officer
10,000
0.0343%
$3.20$32,000+67.40%
2024-04-25PurchaseChief Financial Officer
5,608
0.0189%
$3.14$17,609+67.40%
2024-04-25PurchaseSVP, General Counsel
8,600
0.0299%
$3.24$27,864+67.40%
2024-02-06PurchaseChief Executive Officer
20,000
0.0784%
$4.39$87,800+36.63%
2024-01-17Saledirector
7,084
0.0285%
$5.11$36,199+10.54%
2023-09-27Saledirector
5,508
0.022%
$3.91$21,542+20.96%
2023-09-27Saledirector
6,330
0.0252%
$3.91$24,721+20.96%
2023-09-27Saledirector
7,246
0.0288%
$3.90$28,270+20.96%
2023-09-27Saledirector
8,330
0.0417%
$4.91$40,924+20.96%
2023-09-27Saledirector
6,316
0.0252%
$3.91$24,724+20.96%
2023-09-27PurchaseChief Executive Officer
20,000
0.083%
$4.07$81,400+20.96%
2023-09-20Saledirector
327
0.0014%
$3.90$1,275+25.53%
2023-09-19PurchaseChief Financial Officer
3,000
0.0122%
$3.82$11,458+25.59%
2023-09-18PurchaseSVP, General Counsel
3,000
0.0125%
$3.80$11,400+29.70%
2023-06-20Saledirector
338
0.0039%
$4.45$1,504-3.52%
2023-04-25Saledirector
887
0.0105%
$3.25$2,883+31.60%

Insider Historical Profitability

<0.0001%
Seshadri VishwasChief Executive Officer
538260
1.2382%
$5.9330
Vazzano Joseph WalterChief Financial Officer
233868
0.538%
$5.9330<0.0001%
O'Malley Brendan M.SVP, General Counsel
188718
0.4341%
$5.9345<0.0001%
Alland Leiladirector
82857
0.1906%
$5.9311
Charles Faith L.director
78323
0.1802%
$5.9311
Silverstein Christine Bernidirector
62063
0.1428%
$5.9302
Alvino Markdirector
36926
0.0849%
$5.9306
SCO CAPITAL PARTNERS LLC
11079292
25.4866%
$5.93011
Ayer Capital Management, LP10 percent owner
2413163
5.5512%
$5.9304
CARR EDWARDChief Financial Officer
400169
0.9205%
$5.9304
Ahn Mark Jdirector
343182
0.7895%
$5.9320<0.0001%
Rouhandeh Steven H
315042
0.7247%
$5.9310+20.49%
FEINBERG LARRY N10 percent owner
296483
0.682%
$5.93511
Buono Stefanodirector
270000
0.6211%
$5.9330<0.0001%
GRAY KERRY PPresident and CEO
183340
0.4218%
$5.9320
Amoroso Michaeldirector
108957
0.2506%
$5.9307
MCDADE HERBERT Hdirector
81007
0.1863%
$5.9301
Howell Stephen B.director
79494
0.1829%
$5.9310<0.0001%
Jeffrey B Davisdirector
67858
0.1561%
$5.9310+20.49%
NOWOTNIK DAVID PSr Vice President R&D
62000
0.1426%
$5.9310
Meakem John Jdirector
45000
0.1035%
$5.9330
Van Duyne Richard Bdirector
6000
0.0138%
$5.9310<0.0001%
Wider Todddirector
0
0%
$5.9328<0.0001%
Mann Paul Elliotdirector
0
0%
$5.9306

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Adage Capital Partners Gp L L C$23.56M7.933.25M0%+$00.04
Nantahala Capital Management Llc$16.75M5.642.31M+2.68%+$437,813.000.78
Millennium Management LLC$14.4M4.851.99M+40.03%+$4.12M0.01
Western Standard Llc$9.87M3.321.36M+68.48%+$4.01M13.34
The Vanguard Group$7.99M2.691.1M+0.07%+$5,995.75<0.0001
Ikarian Capital LLC$6.44M2.17888,593+48.1%+$2.09M0.89
Laurion Capital Management LP$4.69M1.58646,830New+$4.69M0.03
Citigroup$3.51M1.18484,054+7.49%+$244,375.79<0.01
Boothbay Fund Management LLC$1.96M0.66270,340+68.69%+$798,080.000.06
Walleye Capital$1.93M0.65266,114+41.54%+$566,210.650.01
Geode Capital Management$1.75M0.59241,791+10.21%+$162,483.46<0.0001
BlackRock$1.6M0.54220,549+18.34%+$247,768.87<0.0001
Goldman Sachs$1.24M0.42171,533New+$1.24M<0.0001
Marshall Wace$934,548.000.32128,903+169.36%+$587,591.54<0.01
Northern Trust$933,082.000.31128,701-2.44%-$23,359.49<0.0001
BNY Mellon$862,885.000.29119,019+793.54%+$766,315.31<0.0001
State Street$623,464.000.2185,995+11.69%+$65,250.03<0.0001
Man Group Plc$535,224.000.1873,824New+$535,224.00<0.01
Renaissance Technologies$535,000.000.1873,837-59.52%-$786,563.10<0.01
Qube Research & Technologies$527,786.000.1872,798+3,978.32%+$514,844.74<0.01
Hrt Financial Llc$500,000.000.1769,051New+$500,000.00<0.01
Jane Street Capital$467,705.000.1664,511+57.78%+$171,274.09<0.0001
Barclays$409,000.000.1456,394-66.78%-$821,988.90<0.0001
Morgan Stanley$225,005.000.0831,035+96.04%+$110,229.61<0.0001
LINSCO PRIVATE LEDGER CORP$221,415.000.0830,540+4.09%+$8,700.00<0.0001
Susquehanna International Group$199,129.000.0727,466-33.27%-$99,281.75<0.0001
Jump Financial Llc$184,440.000.0625,440-36.01%-$103,798.25<0.01
Gsa Capital Partners Llp$178,000.000.0624,561New+$178,000.000.01
Bank of America$166,816.000.0623,009-54.95%-$203,464.92<0.0001
J. Goldman & Company$164,938.000.0622,750-94.71%-$2.95M0.01
JPMorgan Chase$157,065.000.0521,664+154,642.86%+$156,963.50<0.0001
Balyasny Asset Management Llc$137,939.000.0519,026New+$137,939.00<0.0001
Engineers Gate Manager Lp$128,760.000.0417,760New+$128,760.00<0.01
Tower Research Capital$117,015.000.0416,140+701.39%+$102,413.50<0.01
Creative Planning$108,786.000.0415,005New+$108,786.00<0.0001
Squarepoint Ops LLC$105,270.000.0414,520+45.2%+$32,770.00<0.0001
Palumbo Wealth Management$104,168.000.0414,368New+$104,168.000.05
Ci Private Wealth Llc$100,790.000.0313,9020%+$0<0.0001
Y Intercept Hong Kong Ltd$101,667.000.0314,023+34.66%+$26,165.310.01
Acadian Asset Management$91,000.000.0312,634New+$91,000.00<0.0001
OMERS$89,900.000.0312,400New+$89,900.00<0.01
UBS$75,814.000.0310,457New+$75,814.00<0.0001
Simplex Trading Llc$15,000.000.012,154-54.82%-$18,203.34<0.0001
Group One Trading$12,738.00<0.011,757+129.37%+$7,184.61<0.0001
Advisor Group Holdings Inc$8,011.00<0.011,105-57.58%-$10,874.66<0.0001
LAZARD ASSET MANAGEMENT LLC$7,000.00<0.011,124New+$7,000.00<0.0001
Royal Bank of Canada$6,000.00<0.01800-20.71%-$1,567.50<0.0001
Macquarie Group$6,000.00<0.01760New+$6,000.00<0.0001
Hartford Financial Management Inc$5,220.00<0.017200%+$0<0.01
Parallel Advisors, LLC$2,900.00<0.014000%+$0<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.